[The German haemophilia register]

B Haschberger1, J Hesse, M Heiden

  • 1Paul-Ehrlich-Institut, Postfach, 63207 Langen, Germany. hasbi@pei.de

Hamostaseologie
|November 5, 2008
PubMed

Insights

The German Haemophilia Register (DHR) is being developed by the Paul-Ehrlich-Institut (PEI) in collaboration with patient organizations and the GTH. Data security and patient rights are prioritized, leading to a slight delay in the online launch.

Area of Science:

  • Public Health
  • Medical Informatics
  • Patient Registries

Context:

  • The Paul-Ehrlich-Institut (PEI) initiated the development of the German Haemophilia Register (DHR) in December 2004.
  • A collaboration contract was signed in February 2007 by patient organizations (DHG, IGH), the GTH, and the PEI, establishing the PEI as the responsible entity for the DHR's creation and operation.

Purpose:

  • To establish a comprehensive German Haemophilia Register (DHR) for collecting and managing patient health data.
  • To ensure robust data protection and patient privacy in compliance with German data protection regulations.

Summary:

  • The DHR project involves a steering committee with representatives from all involved parties.
  • A data protection concept was developed and approved by data protection representatives in May 2007.
  • Database programming was accepted in February 2008, followed by a testing period involving adaptations and enlargements.

Impact:

  • The implementation of stringent security measures, as mandated by data protection authorities, has led to a delay in the DHR's official online launch.
  • The DHR aims to enhance the management and understanding of haemophilia within Germany.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...